Cervix BT - 2016

CERVICAL CANCER

 3 rd most common gynecologic malignancy

 Clinical staging can under- or over-stage disease  Accurate Tumor size not determined  Nodal status not determined  Parametrial assessment,Pelvic side wall ?

 Concordance between surgical and clinical FIGO staging poor (85.4, 77.4, 35.3, and 20.5% for stage IB, IB2, IIA, and IIB) Qin Y et al. Aust N Z J Obstet Gynaecol 49.5 (2009): 542-544

18